Annual CFI
$344.00 K
+$366.00 K+1663.64%
December 31, 2021
Summary
- As of February 10, 2025, GMTX annual cash flow from investing activities is $344.00 thousand, with the most recent change of +$366.00 thousand (+1663.64%) on December 31, 2021.
- During the last 3 years, GMTX annual CFI has risen by +$366.00 thousand (+1663.64%).
Performance
GMTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
$0.00
NaN%
September 30, 2022
Summary
- As of February 10, 2025, GMTX quarterly cash flow from investing activities is $0.00
- Over the past year, GMTX quarterly CFI has increased by +$61.00 thousand (+100.00%).
Performance
GMTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
$405.00 K
NaN%
September 30, 2022
Summary
- As of February 10, 2025, GMTX TTM cash flow from investing activities is $405.00 thousand
- Over the past year, GMTX TTM CFI has increased by +$466.00 thousand (+763.93%).
Performance
GMTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
GMTX Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +1663.6% | +100.0% | +763.9% |
3 y3 years | +1663.6% | - | - |
5 y5 years | +1663.6% | - | - |
GMTX Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | at low | -100.0% | at low | at high | -15.1% |
5 y | 5-year | at high | -106.4% | -100.0% | <-9999.0% | at high | -115.1% |
alltime | all time | at high | -106.4% | -100.0% | <-9999.0% | at high | -115.1% |
Gemini Therapeutics Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2022 | - | $0.00(-100.0%) | $405.00 K(+17.7%) |
Dec 2021 | $344.00 K | $405.00 K(-763.9%) | $344.00 K(-663.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | -$61.00 K(<-9900.0%) | -$61.00 K(+177.3%) |
Dec 2020 | -$22.00 K | $0.00(-100.0%) | -$22.00 K(0.0%) |
Sep 2020 | - | -$22.00 K | -$22.00 K |
FAQ
- What is Gemini Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Gemini Therapeutics?
- What is Gemini Therapeutics annual CFI year-on-year change?
- What is Gemini Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Gemini Therapeutics?
- What is Gemini Therapeutics quarterly CFI year-on-year change?
- What is Gemini Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Gemini Therapeutics?
- What is Gemini Therapeutics TTM CFI year-on-year change?
What is Gemini Therapeutics annual cash flow from investing activities?
The current annual CFI of GMTX is $344.00 K
What is the all time high annual CFI for Gemini Therapeutics?
Gemini Therapeutics all-time high annual cash flow from investing activities is $344.00 K
What is Gemini Therapeutics annual CFI year-on-year change?
Over the past year, GMTX annual cash flow from investing activities has changed by +$366.00 K (+1663.64%)
What is Gemini Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of GMTX is $0.00
What is the all time high quarterly CFI for Gemini Therapeutics?
Gemini Therapeutics all-time high quarterly cash flow from investing activities is $405.00 K
What is Gemini Therapeutics quarterly CFI year-on-year change?
Over the past year, GMTX quarterly cash flow from investing activities has changed by +$61.00 K (+100.00%)
What is Gemini Therapeutics TTM cash flow from investing activities?
The current TTM CFI of GMTX is $405.00 K
What is the all time high TTM CFI for Gemini Therapeutics?
Gemini Therapeutics all-time high TTM cash flow from investing activities is $405.00 K
What is Gemini Therapeutics TTM CFI year-on-year change?
Over the past year, GMTX TTM cash flow from investing activities has changed by +$466.00 K (+763.93%)